Qun Li
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Nontargeted metabolomics uncovering metabolite signatures in glioblastoma: a preliminary study on candidate biomarker discovery for IDH subtyping and survival prediction.
Journal: Frontiers in oncology
Published: January 28, 2025
Exploring causal correlations of inflammatory biomarkers in idiopathic normal-pressure hydrocephalus: insights from bidirectional Mendelian randomization analysis.
Journal: Frontiers in aging neuroscience
Published: April 04, 2024
Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
Journal: Journal of neuro-oncology
Published: November 05, 2023
The levels of immunosuppressive checkpoint protein PD-L1 and tumor-infiltrating lymphocytes were integrated to reveal the glioma tumor microenvironment.
Journal: Environmental toxicology
Published: July 15, 2023
Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology.
Journal: Frontiers in pharmacology
Published: October 22, 2022
Construction and validation of a glioblastoma prognostic model based on immune-related genes.
Journal: Frontiers in neurology
Published: March 23, 2022
A Multielement Prognostic Nomogram Based on a Peripheral Blood Test, Conventional MRI and Clinical Factors for Glioblastoma.
Journal: Frontiers in neurology
Published: November 26, 2021
Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1.
Journal: Frontiers in pharmacology
Published: September 14, 2021
Surgery and Medical Treatment in Microprolactinoma: A Systematic Review and Meta-Analysis.
Journal: International journal of endocrinology
Published: May 15, 2021
Radiomic features as a risk factor for early postoperative seizure in patients with meningioma.
Journal: Seizure
Published: April 20, 2021
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.
Journal: Oxidative medicine and cellular longevity
Published: December 06, 2020
Last Updated: 09/26/2026